Company Monitoring Page for Aegerion

latest headlines for company on cafepharma

Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Fierce Biotech
Wed, 09/25/19 - 09:52 am
Tags:
Amryt Pharma, Aegerion, M&A, R&D, bankruptcy, AP101
6 Biopharma Movers Making a Run on Wednesday
24/7 Wall St
Wed, 06/15/16 - 05:50 pm
Tags:
Aegerion, Cellectar, Infinity Pharma, AbbVie, QLT
Aegerion to plead guilty to misbranding cholesterol drug, will pay $40 million
BioPharma Dive
Fri, 05/13/16 - 10:17 am
Tags:
Aegerion, misbranding, Juxtapid, DOJ, SEC
3 Biotech Stocks That Are Getting a Heckuva Lot Riskier
Motley Fool
Mon, 08/17/15 - 07:58 am
Tags:
Ironwood Pharmaceuticals, Aegerion, MannKind
Aegerion's embattled CEO Beer steps down
Fierce Biotech
Fri, 07/31/15 - 03:28 pm
Tags:
Aegerion, Marc Beer
Aegerion Buys Rare Disease Therapy, Seeking Path Out of Current Troubles
TheStreet.com
Thu, 11/6/14 - 08:19 am
Tags:
Aegerion, Myalept, AstraZeneca, lipodystrophy
Aegerion Board Expresses Support for Embattled CEO Amid Drug Use Accusations
TheStreet.com
Wed, 10/29/14 - 09:38 am
Tags:
Aegerion, Pharma CEOs, Marc Beer
Aegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use
TheStreet.com
Mon, 10/27/14 - 10:50 am
Tags:
Aegerion, Seattle Genetics, Pharma CEOs
Aegerion says FDA investigation into off-label marketing is closed
Bizjournals.com
Thu, 08/28/14 - 10:10 am
Tags:
Aegerion, off-label, FDA
3 Biotech Stocks Falling Like a Knife: Aegerion, Insys, and Prothena
Motley Fool
Tue, 05/27/14 - 09:51 pm
Tags:
Aegerion, Insys, Prothena
Aegerion's Rare Disease Drug Launch Stalls
TheStreet.com
Wed, 05/7/14 - 08:58 am
Tags:
Aegerion, drug launches, Juxtapid, earnings
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Tags:
Juxtapid, Otezla, Aegerion, Celgene, GW Pharma, Sativex, Intercept Pharma, OCA, Ironwood Pharmaceuticals, Linzess, Lpath, iSONEP, MannKind, Afrezza, Xtandi, H.P. Acthar Gel, Questcor Pharmaceuticals, eteplirsen, Sarepta Therapeutics
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Mon, 03/10/14 - 08:23 am
Tags:
InterMune, Aegerion, Emergent BioSolutions
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
Forbes
Mon, 03/3/14 - 08:12 am
Tags:
InterMune, Prana Biotechnology, Cara Therapeutics, Prothena, Endologix, Ampio Pharmaceuticals, Questcor Pharmaceuticals, Aegerion
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit on Behalf of Investors of Aegerion Pharmaceuticals, Inc.
Yahoo/BusinessWire
Sat, 01/25/14 - 10:55 am
Tags:
Aegerion, lawsuits
Aegerion gets DOJ subpeona over marketing of cholesterol drug Juxtapid
Yahoo/Reuters
Fri, 01/10/14 - 08:23 am
Tags:
DOJ, Juxtapid, Aegerion
Aegerion expects to initiate pediatric study of lomitapide in 2014
Yahoo/Fly on the Wall
Fri, 01/10/14 - 08:22 am
Tags:
Aegerion, lomitapide, pediatrics, familial hypercholesterolemia
November's 3 Biggest Biotech Busts
Motley Fool
Mon, 12/2/13 - 08:31 am
Tags:
Immunogen, Aegerion, eteplirsen, Sarepta Therapeutics
Aegerion reports results from Phase 3 study of Juxtapid
Yahoo/Fly on the Wall
Tue, 11/19/13 - 07:27 am
Tags:
Aegerion, Juxtapid, Homozygous Familial Hypercholesterolemia
Biotech Stock Bubble Debate in 14 Charts
TheStreet.com
Wed, 10/23/13 - 08:32 am
Tags:
biotech, Bluebird Bio, Celgene, Celldex, Onconova, Aegerion, Receptos, Immunomedics, Alcobra, Gilead, Biogen Idec, Ambit Biosciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.